Majed A. Refaai, M.D.

Contact Information

Phone Numbers

Office: (585) 276-3927

Fax: (585) 273-3003

A member of the University of Rochester Medical Faculty Group

An Accountable Health Partner

Accepting New Patients

Biography

Dr. Refaai's clinical service is in Transfusion Medicine with subspecialty involvement in laboratory coagulation/thrombosis testing.

Research

Dr. Refaai's recent studies have included: The in-vitro effect of ABO anti-bodies on platelet function; The correlation between cancer and tissue factor (TF) plasma concentrations and its role in developing DVT; The relationship between the circulating TF and the cancer tissue concentrations of TF in different types of mouse models; Beriplex phase IIIb drug study for bleeding patients with Warfarin overdose; Beriplex phase IIIb drug study for surgical patients who require a quick reversal of Warfarin; The effect of ABO non-identical blood products transfusion on platelet function (in-vivo); Platelet transfusion in patients with positive heparin-induced thrombocytopenia; Comparison of tissue factor pathway inhibitor (TFPI) concentration and activity in mononuclear cells from normal individuals versus patients with Paroxysmal Nocturnal Hemoglobinuria; Comparison of TFPI concentrations in normal mouse plasma and endothelial cells versus a diabetic mouse model; Analysis of fatty acid ethyl ester (FAEE) concentrations in binge drinking, chronic alcoholics, and postmortem biopsies.

Credentials

Specialties

Clinical Pathology/Laboratory Medicine - American Board of Pathology

Education

1993
MD | Aleppo University

Post-doctoral Training & Residency

07/01/2006 - 06/30/2007
Fellowship in Tranfusion Medicine at University of Texas Southwestern

06/30/2003 - 06/30/2006
Residency in Pathology at Barnes-Jewish Hospitals

04/01/1997 - 05/31/2003
Research in at Massachusetts General Hospital

VIEW ALL

Patents

Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
Patent #: 3265116
Issue Date: Jun 02, 2021
Country: Europe
Invented By: Majed A Refaai

Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
Patent #: FR3265116
Issue Date: Jun 02, 2021
Country: France
Invented By: Majed A Refaai

Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
Patent #: DE3265116
Issue Date: Jun 02, 2021
Country: Germany
Invented By: Majed A Refaai

Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
Patent #: GB3265116
Issue Date: Jun 02, 2021
Country: United Kingdom
Invented By: Majed A Refaai

Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
Patent #: ZL 201680012653.9
Issue Date: Mar 19, 2021
Country: China, People's Republic of
Invented By: Majed A Refaai

Patent Title: Systemic and Topical Application of Platelet Microparticles to Treat Bleeding in Trauma Patients
Patent #: 10,722,608
Issue Date: Jul 28, 2020
Country: United States
Invented By: Majed A Refaai

VIEW ALL

Publications

Journal Articles

8/31/2021
Cardillo A, Refaai M. "Platelet Recruitment in COVID-19." American journal of clinical pathology.. 2021 Aug 31; Epub 2021 Aug 31.

7/15/2021
Cahill CM, Alhasson B, Blumberg N, Melvin A, Knight P, Gloff M, Robinson R, Akwaa F, Refaai MA. "Preoperative anemia management program reduces blood transfusion in elective cardiac surgical patients, improving outcomes and decreasing hospital length of stay." Transfusion.. 2021 Jul 15; Epub 2021 Jul 15.

6/24/2021
Cardillo A, Heal JM, Henrichs K, Masel D, Fountaine T, Liesveld J, Noronha S, Cahill C, Ngo A, Gupta GK, Refaai MA, Blumberg N. "Reducing the Need for HLA-Matched Platelet Transfusion." The New England journal of medicine.. 2021 Jun 24; 384(25):2451-2452.

VIEW ALL PUBLICATIONS